| The regulation of steroid action by sulfation and desulfation JW Mueller, LC Gilligan, J Idkowiak, W Arlt, PA Foster Endocrine reviews 36 (5), 526-563, 2015 | 431 | 2015 |
| Antiinflammatory activity of soluble guanylate cyclase: cGMP-dependent down-regulation of P-selectin expression and leukocyte recruitment A Ahluwalia, P Foster, RS Scotland, PG McLean, A Mathur, M Perretti, ... Proceedings of the National Academy of Sciences 101 (5), 1386-1391, 2004 | 274 | 2004 |
| Natriuretic peptide receptor-C regulates coronary blood flow and prevents myocardial ischemia/reperfusion injury: novel cardioprotective role for endothelium-derived C-type … A Hobbs, P Foster, C Prescott, R Scotland, A Ahluwalia Circulation 110 (10), 1231-1235, 2004 | 184 | 2004 |
| Steroid sulfatase inhibitors for estrogen-and androgen-dependent cancers A Purohit, PA Foster Journal of Endocrinology 212 (2), 99-110, 2012 | 157 | 2012 |
| 17β‐hydroxysteroid dehydrogenase Type 1, and not Type 12, is a target for endocrine therapy of hormone‐dependent breast cancer JM Day, PA Foster, HJ Tutill, MFC Parsons, SP Newman, SK Chander, ... International journal of cancer 122 (9), 1931-1940, 2008 | 151 | 2008 |
| Quinazolinone-based anticancer agents: synthesis, antiproliferative SAR, antitubulin activity, and tubulin co-crystal structure W Dohle, FL Jourdan, G Menchon, AE Prota, PA Foster, P Mannion, ... Journal of medicinal chemistry 61 (3), 1031-1044, 2018 | 135 | 2018 |
| C-type natriuretic peptide inhibits leukocyte recruitment and platelet-leukocyte interactions via suppression of P-selectin expression RS Scotland, M Cohen, P Foster, M Lovell, A Mathur, A Ahluwalia, ... Proceedings of the National Academy of Sciences 102 (40), 14452-14457, 2005 | 135 | 2005 |
| Protein disulphide isomerase inhibition as a potential cancer therapeutic strategy LE Powell, PA Foster Cancer medicine 10 (8), 2812-2825, 2021 | 84 | 2021 |
| In vivo Efficacy of STX213, A Second-Generation Steroid Sulfatase Inhibitor, for Hormone-Dependent Breast Cancer Therapy PA Foster, SP Newman, SK Chander, C Stengel, R Jhalli, LLW Woo, ... Clinical cancer research 12 (18), 5543-5549, 2006 | 76 | 2006 |
| Oestrogen and colorectal cancer: mechanisms and controversies PA Foster International journal of colorectal disease 28, 737-749, 2013 | 72 | 2013 |
| Structure–activity relationships of C-17 cyano-substituted estratrienes as anticancer agents MP Leese, FL Jourdan, K Gaukroger, MF Mahon, SP Newman, PA Foster, ... Journal of medicinal chemistry 51 (5), 1295-1308, 2008 | 69 | 2008 |
| STX140 is efficacious in vitro and in vivo in taxane-resistant breast carcinoma cells SP Newman, PA Foster, C Stengel, JM Day, YT Ho, JG Judde, M Lassalle, ... Clinical Cancer Research 14 (2), 597-606, 2008 | 61 | 2008 |
| The development of steroid sulfatase inhibitors for hormone‐dependent cancer therapy JM Day, A Purohit, HJ Tutill, PA Foster, LWL Woo, BVL Potter, MJ Reed Annals of the New York Academy of Sciences 1155 (1), 80-87, 2009 | 60 | 2009 |
| 2-Methoxyoestradiol-3,17-O,O-bis-sulphamate and 2-deoxy-D-glucose in combination: a potential treatment for breast and prostate cancer SLC Tagg, PA Foster, MP Leese, BVL Potter, MJ Reed, A Purohit, ... British journal of cancer 99 (11), 1842-1848, 2008 | 59 | 2008 |
| In vivo inhibition of angiogenesis by sulphamoylated derivatives of 2-methoxyoestradiol SK Chander, PA Foster, MP Leese, SP Newman, BVL Potter, A Purohit, ... British journal of cancer 96 (9), 1368-1376, 2007 | 59 | 2007 |
| Sulfation pathways: insights into steroid sulfation and desulfation pathways PA Foster, JW Mueller Journal of molecular endocrinology 61 (2), T271-T283, 2018 | 56 | 2018 |
| Steroid metabolism in breast cancer. PA Foster Minerva endocrinologica 33 (1), 27-37, 2008 | 56 | 2008 |
| NNT is a key regulator of adrenal redox homeostasis and steroidogenesis in male mice E Meimaridou, M Goldsworthy, V Chortis, E Fragouli, PA Foster, W Arlt, ... Journal of Endocrinology 236 (1), 13-28, 2018 | 54 | 2018 |
| A new therapeutic strategy against hormone-dependent breast cancer: the preclinical development of a dual aromatase and sulfatase inhibitor PA Foster, SK Chander, SP Newman, LWL Woo, OB Sutcliffe, C Bubert, ... Clinical cancer research 14 (20), 6469-6477, 2008 | 52 | 2008 |
| The use of steroid sulfatase inhibitors as a novel therapeutic strategy against hormone-dependent endometrial cancer PA Foster, LWL Woo, BVL Potter, MJ Reed, A Purohit Endocrinology 149 (8), 4035-4042, 2008 | 50 | 2008 |